Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced financial results for the first quarter ended March 31, 2024, and provided a business update.
May 8, 2024
· 13 min read
